Stryker (NYSE: SYK) is one of 19 publicly-traded companies in the “Medical Devices & Implants” industry, but how does it weigh in compared to its peers? We will compare Stryker to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, risk, institutional ownership and profitability.
Insider and Institutional Ownership
75.0% of Stryker shares are owned by institutional investors. Comparatively, 54.8% of shares of all “Medical Devices & Implants” companies are owned by institutional investors. 7.4% of Stryker shares are owned by insiders. Comparatively, 11.9% of shares of all “Medical Devices & Implants” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Stryker and its peers gross revenue, earnings per share (EPS) and valuation.
Stryker has higher revenue and earnings than its peers. Stryker is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Stryker has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Stryker’s peers have a beta of 0.21, indicating that their average share price is 79% less volatile than the S&P 500.
This is a summary of recent recommendations and price targets for Stryker and its peers, as reported by MarketBeat.
||Strong Buy Ratings
Stryker presently has a consensus price target of $152.37, suggesting a potential upside of 0.22%. As a group, “Medical Devices & Implants” companies have a potential upside of 39.99%. Given Stryker’s peers stronger consensus rating and higher probable upside, analysts clearly believe Stryker has less favorable growth aspects than its peers.
This table compares Stryker and its peers’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Stryker pays an annual dividend of $1.70 per share and has a dividend yield of 1.1%. Stryker pays out 36.3% of its earnings in the form of a dividend. As a group, “Medical Devices & Implants” companies pay a dividend yield of 1.3% and pay out 42.2% of their earnings in the form of a dividend. Stryker has increased its dividend for 6 consecutive years.
Stryker beats its peers on 9 of the 15 factors compared.
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company’s products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.